Eisai CEO retires

Share this article:

Eisai's president and CEO Lonnel Coats is retiring. The company announced Monday that Coats will leave the company in June, but will hand off his titles April 1, the first day of the company's new fiscal year.

Yuji Matsue will be the new chairman and CEO and will oversee “the strategic direction of the Americas Region.” Shaji Procida, the new president and COO as of April 1, will “have full operating responsibility for the US Business.”

The new executive lineup accompanies an organizational change that also goes into effect April 1. The company noted in its third-quarter earnings for FY 2014 that the pharmaceutical businesses will be designated as follows in FY2015: Japan (prescription drugs, generic drugs and diagnostics), Americas (North, Central and South), Asia (China, South Korea, Taiwan, India and ASEAN), EMEA (Europe, Middle East, Africa and Oceania) and Consumer Healthcare Businesses.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.